Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Journal for Immunotherapy of Cancer
|
August 30, 2019
Isolation of T cell receptor specifically reactive with autologous tumour cells from tumour-infiltrating lymphocytes and construction of T cell receptor engineered T cells for esophageal squamous cell carcinoma
Qin Tan, Chaoting Zhang, Wenjun Yang, et al.
Journal of Hematology & Oncology
|
February 17, 2021
CD19 CAR-T expressing PD-1/CD28 chimeric switch receptor as a salvage therapy for DLBCL patients treated with different CD19-directed CAR T-cell therapies
Yun Liang, Hui Liu, Zheming Lu, et al.
Molecular Cancer
|
November 21, 2020
Pre-depletion of TRBC1+ T cells promotes the therapeutic efficacy of anti-TRBC1 CAR-T for T-cell malignancies
Chaoting Zhang, Heyilimu Palashati, Zhuona Rong, et al.
Cancer Science
|
November 15, 2018
T cell receptor β-chain repertoire analysis of tumor-infiltrating lymphocytes in pancreatic cancer
Can Cui, Xiuyun Tian, Jianhui Wu, et al.
The Journal of Biological Chemistry
|
June 4, 2004
Human papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberin
Zheming Lu, Xiuhua Hu, Yong Li, et al.
Molecular Cancer
|
October 24, 2024
Membrane-bound IL-7 immobilized by the CD8 transmembrane region improves efficacy of CD19 CAR-T cell therapy
Chaoting Zhang, Ting Liu, Shance Li, et al.
Plos One
|
November 10, 2010
Polycomb CBX7 directly controls trimethylation of histone H3 at lysine 9 at the p16 locus
Qiang Li, Xiuhong Wang, Zheming Lu, et al.
International Journal of Biological Sciences
|
May 29, 2026
Redirecting Cholesterol Metabolism During <i>Ex Vivo</i> Biomanufacturing Enhances the Metabolic Fitness and Antitumor Efficacy of CAR-T Cells
Yuge Zhu, Jiaxin Tu, Shuang Li, et al.
Experimental Hematology & Oncology
|
April 4, 2025
NKG2D/CD28 chimeric receptor boosts cytotoxicity and durability of CAR-T cells for solid and hematological tumors
Xia Teng, Shance Li, Chaoting Zhang, et al.
Cancer Research
|
November 19, 2009
Glioblastoma proto-oncogene SEC61gamma is required for tumor cell survival and response to endoplasmic reticulum stress
Zheming Lu, Lei Zhou, Patrick Killela, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Journal for Immunotherapy of Cancer
|
August 30, 2019
Isolation of T cell receptor specifically reactive with autologous tumour cells from tumour-infiltrating lymphocytes and construction of T cell receptor engineered T cells for esophageal squamous cell carcinoma
Qin Tan, Chaoting Zhang, Wenjun Yang, et al.
Journal of Hematology & Oncology
|
February 17, 2021
CD19 CAR-T expressing PD-1/CD28 chimeric switch receptor as a salvage therapy for DLBCL patients treated with different CD19-directed CAR T-cell therapies
Yun Liang, Hui Liu, Zheming Lu, et al.
Molecular Cancer
|
November 21, 2020
Pre-depletion of TRBC1+ T cells promotes the therapeutic efficacy of anti-TRBC1 CAR-T for T-cell malignancies
Chaoting Zhang, Heyilimu Palashati, Zhuona Rong, et al.
Cancer Science
|
November 15, 2018
T cell receptor β-chain repertoire analysis of tumor-infiltrating lymphocytes in pancreatic cancer
Can Cui, Xiuyun Tian, Jianhui Wu, et al.
The Journal of Biological Chemistry
|
June 4, 2004
Human papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberin
Zheming Lu, Xiuhua Hu, Yong Li, et al.
Molecular Cancer
|
October 24, 2024
Membrane-bound IL-7 immobilized by the CD8 transmembrane region improves efficacy of CD19 CAR-T cell therapy
Chaoting Zhang, Ting Liu, Shance Li, et al.
Plos One
|
November 10, 2010
Polycomb CBX7 directly controls trimethylation of histone H3 at lysine 9 at the p16 locus
Qiang Li, Xiuhong Wang, Zheming Lu, et al.
International Journal of Biological Sciences
|
May 29, 2026
Redirecting Cholesterol Metabolism During <i>Ex Vivo</i> Biomanufacturing Enhances the Metabolic Fitness and Antitumor Efficacy of CAR-T Cells
Yuge Zhu, Jiaxin Tu, Shuang Li, et al.
Experimental Hematology & Oncology
|
April 4, 2025
NKG2D/CD28 chimeric receptor boosts cytotoxicity and durability of CAR-T cells for solid and hematological tumors
Xia Teng, Shance Li, Chaoting Zhang, et al.
Cancer Research
|
November 19, 2009
Glioblastoma proto-oncogene SEC61gamma is required for tumor cell survival and response to endoplasmic reticulum stress
Zheming Lu, Lei Zhou, Patrick Killela, et al.
Page
of 6